Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
Clinical Endocrinology, EarlyView.ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
Administration of Dydrogesterone in First Trimester of Pregnancy Will Increase the Level of PlGF (Placental Growth Factor) [PDF]
, 2013 Early placental development can be determined by measuring placental growth factor or Placental growth factor (PlGF) through the mother's blood since the first trimester of pregnancy.
Hasballah, K. (Kartini) +3 more
core
Identifying signals of potentially harmful medications in pregnancy: use of the double false discovery rate method to adjust for multiple testing. [PDF]
, 2018 AIMS: Surveillance of medication use in pregnancy is essential to identify associations between first trimester medications and congenital anomalies (CAs). Medications in the same Anatomical Therapeutic Chemical classes may have similar effects. We aimed
Cavadino, A +2 more
core +2 more sources
Progesterone, progestins and psychosomatic health of women [PDF]
, 2017 Psychosomatics as a medical perspective and discipline focuses on the interaction of physical and mental health in the specific life situation of a patient, taking into account the physical and emotional well-being, role functioning, satisfaction with ...
Bitzer, Johannes
core
Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome [PDF]
, 2002 GH treatment increases insulin levels in girls with Turner syndrome (TS), who are already predisposed to develop diabetes mellitus and other risk factors for developing cardiovascular disease.
Drop, S.L.S. (Stenvert) +4 more
core +3 more sources
FIGO best practice recommendations for the mental health of women at menopausal age
International Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 588-601, May 2026.Abstract Mental health during the menopausal transition requires focused attention to ensure supportive experiences for women. This review presents the International Federation of Gynecology and Obstetrics (FIGO) recommendations and summarizes the evidence, addressing 13 key questions framed by members of the FIGO Committee on Women at Menopausal Age ...
Suvarna Khadilkar +10 more
wiley +1 more source
Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis [PDF]
, 2019 Objective The purpose of this study was to perform a systematic review and metaanalysis of randomized controlled trials on oral progesterone compared with placebo or other interventions for preterm birth prevention in singleton pregnancies with ...
Ashoush, Sherif +6 more
core +1 more source
Real-world evaluation of safety and effectiveness of dydrogesterone in the management of threatened abortion [PDF]
, 2022 Background: Threatened abortion is a relatively common complication during pregnancy. Inadequate production of endogenous progesterone is implicated as a risk factor for miscarriages.
Chinda, Monika +7 more
core +3 more sources
Immunity, Inflammation and Disease, Volume 14, Issue 4, April 2026.ABSTRACT Purpose This study aimed to evaluate the pregnancy outcomes of frozen embryo transfer (FET) in patients with persistent chronic endometritis (PCE). Methods 186 patients were stratified into three groups: Cured CE (CCE), Cured Persistent CE (CPCE), and Still Persistent CE (SPCE). Only the first post‐treatment FET cycle per patient was analyzed.
Yihua Liang +5 more
wiley +1 more source
Molecular Oncology, Volume 20, Issue 1, Page 117-133, January 2026.The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat +18 more
wiley +1 more source